Stocktoria

CHAMPIONS ONCOLOGY, INC. CSBR

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1988-11-30 · LEI

CHAMPIONS ONCOLOGY, INC. statistics & valuation

Market cap$92.1M
P / S1.5×
P / B22.6×
Net margin-2.0%
Return on equity-28.9%
FCF margin-8.5%
Return on capital-16.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-7.30% 0.50% -6.50% 0.90% 1.10% -9.90% -14.50% 8.30% -2.00% 2017201820192020202120222023202420252026
Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
-6.70% 1.00% -6.00% 0.90% 1.20% -9.80% -14.70% 8.00% -1.90% 2017201820192020202120222023202420252026
Return on equity (%)
-1721.00% -49200.00% 6.00% -41.00% 4.90% 6.00% -115.10% 124.60% -28.90% 2017201820192020202120222023202420252026
Shares outstanding
11.0M 11.0M 14.1M 12.7M 14.6M 14.2M 13.5M 13.6M 14.3M 13.9M 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-85.90% -18.30% 1.10% -10.10% 1.30% 1.50% -15.50% -27.80% 14.50% -4.40% 2017201820192020202120222023202420252026
Free cash flow margin (%)
-12.10% 3.80% 2.10% -12.10% 8.40% 2.00% -13.90% 12.30% -8.50% 2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
-$0.13 $0.01 -$0.18 $0.02 $0.04 -$0.39 -$0.54 $0.33 -$0.08 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

CHAMPIONS ONCOLOGY, INC. trades at about 15× earnings — below its 10-year norm (10-year range 17.8×–936×, median 470.5×).

15× 936×

Shaded band = 10-year range (17.8×–936×); dot = today's 15×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-1.9%8.0%-14.7%-9.8%1.2%0.9%-6.0%1.0%-6.7%—
Net margin-2.0%8.3%-14.5%-9.9%1.1%0.9%-6.5%0.5%-7.3%—
FCF margin-8.5%12.3%-13.9%2.0%8.4%-12.1%2.1%3.8%-12.1%—
Return on assets-4.4%14.5%-27.8%-15.5%1.5%1.3%-10.1%1.1%-18.3%-85.9%
Return on equity-28.9%124.6%382.3%-115.1%6.0%4.9%-41.0%6.0%-49200.0%-1721.0%
Current ratio0.960.940.630.901.131.131.100.990.680.79

Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.